Inclusive Digital Care for Chronic Kidney Disease
Official title: INCLUDE-CKD: INCLUsive Digital carE for Chronic Kidney Disease
Run by Portsmouth Hospitals NHS Trust · NCT07613593 · Data updated 2026-11-12
This study looks at how the MyRenalCare app is used by adults with CKD and what impact it has on their health, costs, and environment.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Portsmouth Hospitals NHS Trust Government |
| Locations | 1 site (Portsmouth, Hampshire) |
| Status | Recruiting |
| Started | June 12, 2026 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | July 6, 2026 |
| Trial ID | NCT07613593 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) with CKD receiving care at the Wessex Kidney Centre who are or were enrolled on the MyRenalCare platform during defined retrospective or prospective periods.
✕Probably not a fit
Patients not using the MyRenalCare platform or outside the defined study periods may not see any demonstrated benefit from this analysis.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational analysis will examine retrospective and prospective cohorts of adults with chronic kidney disease who are users of the MyRenalCare platform at the Wessex Kidney Centre. The study will describe user demographics, digital adherence, and associations with health outcomes, healthcare costs, and environmental sustainability. It will include matched usual-care controls to provide context for comparisons. Data will be collected through existing platform records and medical data, with appropriate consent for research use where applicable.
Why it matters
Potential benefit: If successful, findings could inform how digital kidney-care tools affect outcomes and resource use for CKD patients.
How similar studies have gone: Prior analyses of digital health platforms in CKD have shown insights into adherence and outcomes, but this study adds a UK-center, real-world cohort with matched controls.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 5.1.1 Inclusion criteria - MyRenalCare users (retrospective and prospective cohorts) Adults will be eligible for inclusion in the MyRenalCare cohorts if they meet all of the following: 1. Aged 18 years or over. 2. Under the care of the Wessex Kidney Centre 3. Registered with, or offered and subsequently enrolled onto, the MyRenalCare platform during the defined retrospective or prospective periods. 4. Able to understand study information and, where applicable, provide informed consent for use of their data for research purposes. Specific CKD stage definitions and thresholds (e.g. based on eGFR, albuminuria or uPCR) will be documented in the study manual to ensure consistent application. 5.1.2 Inclusion criteria - matched usual care controls Adults will be eligible for inclusion in the matched control cohorts if they meet all of the following: 1. Aged 18 years or over. 2. Under the care of the Wessex Kidney Centre for chronic kidney disease. 3. Not registered with or using MyRenalCare at any point during the relevant observation period. 4. Have sufficient clinical and administrative data available in the renal electronic patient record to enable matching and outcome assessment. Controls will be identified retrospectively from the renal electronic patient record and matched to MyRenalCare users using a predefined matching strategy. 5.1.3 Inclusion criteria - qualitative interview participants (patients and staff) Patients will be eligible to take part in the qualitative interview component if they meet all of the following: 1. Aged 18 years or over. 2. Currently using, or recently offered, the MyRenalCare platform as part of their CKD care at the Wessex Kidney Centre. 3. Able to understand spoken and written English to the extent required for participation in an interview. 4. Able and willing to provide written informed consent for participation in a recorded interview. 5. Belong to a demographic or clinical subgroup of interest for the study (e.g. varying age, ethnicity, CKD stage, or digital engagement level), as part of purposive sampling to support diversity and equity analysis. Clinical staff will be eligible if they meet all of the following: 1. Employed by PHU or working in direct partnership with the Wessex Kidney Centre. 2. Directly involved in the care of patients with chronic kidney disease and/or in the implementation or support of MyRenalCare. 3. Able and willing to provide informed consent for a recorded interview. 4. Able to reflect on experiences and observations relevant to the delivery, uptake, or equity implications of digital health in CKD. Exclusion Criteria: 1. Patients with acute kidney injury without established chronic kidney disease. 2. Patients with a very limited life expectancy where participation in routine digital monitoring is not appropriate, as judged by the clinical team. 3. Patients who have previously indicated that they do not wish their routinely collected clinical data to be used for research where such opt-out applies to this study. 4. Patients who are unable to be identified reliably in the available data sources (for example, inconsistent or missing key identifiers). 5. Any other situation where, in the opinion of the responsible clinician, participation in the study processes (including data use) would be inappropriate or unduly burdensome. 6. Clinical staff who are not directly involved in the care of patients with chronic kidney disease or in the implementation of the MyRenalCare platform. 7. Staff members currently on extended leave or unable to participate during the data collection period. 8. Individuals who do not wish to have their views included in recorded interview transcripts or are unable to provide informed consent for participation. 9. Any situation where, in the opinion of the study team or the individual's manager, participation would be inappropriate or burdensome due to role, availability, or conflict of interest.
Where it's running
-
Portsmouth Hospitals University NHS Trust
Portsmouth, Hampshire, United Kingdom Recruiting
Study contacts
- Study coordinator: Sam Newman
- Email: sam.newman6@nhs.net
- Phone: +442392286000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Observational look at how Kremezin works in adults with advanced chronic kidney disease
This study tests whether Kremezin helps adults with advanced kidney disease when used as part of routine care, by tracking safety and kidney function over up to 48 weeks.
-
Kidney and Heart Health in Adults with Type 2 Diabetes and CKD Treated with Semaglutide in China
This study tests whether semaglutide injections help kidney and heart health in adults with type 2 diabetes and chronic kidney disease.
-
High BMI and periodontitis in Thai adults under 60
This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.
-
Optimised Cardio-Renal Care for CKD and heart disease
This study tests whether a specialised Cardio-Renal Clinic can improve heart and kidney health and quality of life for adults with chronic kidney disease and cardiovascular disease.
-
NMR-based Risk Test and Digital Health Support for midlife adults in Eloisa
This study tests whether an NMR metabolomics risk test can guide tailored digital health programs for midlife adults at risk of diabetes, heart disease, stroke, kidney disease, or fatty liver.
-
Arterial stiffness in children and young people with CKD and hypertension
This study will test whether arterial stiffness is higher in children and young people with chronic kidney disease and high blood pressure compared with their peers, using a one-time assessment and follow-up for those with high BP.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.